ZAVEGEPANT

ZAVEGEPANT was reported 892 times

ZAVEGEPANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THYROID ATROPHY 10 0.1064
1 EXPLODING HEAD SYNDROME 1 0.0312
2 CONCOMITANT DRUG EFFECT DECREASED 1 0.0233
3 PHARYNGEAL ENANTHEMA 1 0.0164
4 RESPIRATORY DYSKINESIA 1 0.0108
5 NASAL DISCOMFORT 85 0.0107
6 STATUS MIGRAINOSUS 1 0.0062
7 URINARY RETENTION POSTOPERATIVE 1 0.0061
8 SWELLING OF NOSE 1 0.0058
9 CATHETER SITE NODULE 1 0.0052
10 VIRAL PERICARDITIS 1 0.0048
11 RHINALGIA 10 0.0036
12 DYSGEUSIA 259 0.0035
13 URINE CALCIUM INCREASED 1 0.0032
14 COLD-STIMULUS HEADACHE 1 0.0031
15 DERMOID CYST 1 0.0030
16 TACHYPHYLAXIS 1 0.0029
17 BURNING SENSATION MUCOSAL 1 0.0028
18 VIRAL MYOCARDITIS 1 0.0027
19 SENSATION OF BLOOD FLOW 1 0.0026
20 SINUS PAIN 6 0.0026
21 HUMIDITY INTOLERANCE 1 0.0025
22 VITAMIN B12 DEFICIENCY 10 0.0025
23 EXPOSURE VIA EYE CONTACT 1 0.0024
24 LACK OF SPONTANEOUS SPEECH 1 0.0023
25 PHARYNGEAL ULCERATION 3 0.0023
26 ESSENTIAL HYPERTENSION 4 0.0022
27 UPPER-AIRWAY COUGH SYNDROME 18 0.0022
28 DRAINAGE 1 0.0020
29 SENSORIMOTOR DISORDER 1 0.0020
30 MALABSORPTION 10 0.0019
31 INFUSION SITE CELLULITIS 1 0.0019
32 PRODUCT CLOSURE ISSUE 1 0.0018
33 TASTE DISORDER 36 0.0018
34 BURN ORAL CAVITY 1 0.0017
35 THROAT IRRITATION 75 0.0017
36 MEAN PLATELET VOLUME INCREASED 1 0.0017
37 PROCTALGIA 10 0.0016
38 PRODUCT INEFFECTIVE 1 0.0013
39 OESOPHAGEAL PERFORATION 1 0.0012
40 INFECTED BITE 1 0.0012
41 TONGUE PRURITUS 1 0.0012
42 PHARYNGEAL HYPOAESTHESIA 1 0.0011
43 PRODUCT AFTER TASTE 1 0.0010
44 INFUSION SITE NODULE 1 0.0010
45 INFUSION SITE DISCOMFORT 1 0.0010
46 NASAL INFLAMMATION 1 0.0009
47 INNER EAR DISORDER 1 0.0009
48 CATHETER SITE DISCHARGE 1 0.0009
49 BENIGN NEOPLASM 1 0.0009
50 PRODUCT TASTE ABNORMAL 12 0.0009
51 REGURGITATION 3 0.0009
52 CARBON DIOXIDE DECREASED 1 0.0009
53 ADMINISTRATION SITE PAIN 1 0.0009
54 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
55 MYOCLONUS 10 0.0008
56 POST-ACUTE COVID-19 SYNDROME 1 0.0008
57 HYPERACUSIS 3 0.0008
58 PARANASAL SINUS DISCOMFORT 3 0.0008
59 ENDOCRINE DISORDER 1 0.0008
60 OROPHARYNGEAL DISCOMFORT 7 0.0008
61 NASAL DISORDER 2 0.0008
62 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
63 ANION GAP INCREASED 1 0.0007
64 THERAPEUTIC PROCEDURE 1 0.0007
65 MAST CELL ACTIVATION SYNDROME 1 0.0007
66 INJECTION SITE HYPOAESTHESIA 1 0.0007
67 MENTAL FATIGUE 1 0.0007
68 ORAL MUCOSAL ERYTHEMA 1 0.0006
69 INHIBITORY DRUG INTERACTION 1 0.0006
70 PRE-ECLAMPSIA 3 0.0006
71 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 44 0.0006
72 COSTOCHONDRITIS 1 0.0006
73 MITRAL VALVE PROLAPSE 1 0.0006
74 TROPONIN I INCREASED 1 0.0006
75 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
76 HYPERLIPIDAEMIA 7 0.0006
77 BLADDER NEOPLASM 1 0.0006
78 EAR PRURITUS 2 0.0006
79 HAEMORRHOIDS 11 0.0006
80 NASAL OEDEMA 1 0.0006
81 OESOPHAGEAL SPASM 1 0.0005
82 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
83 NASAL OBSTRUCTION 1 0.0005
84 PHARYNGEAL SWELLING 5 0.0005
85 EMPYEMA 1 0.0005
86 SLEEP DEFICIT 1 0.0005
87 MIGRAINE 45 0.0005
88 TENSION HEADACHE 2 0.0005
89 INFUSION SITE BRUISING 1 0.0005
90 FAECES PALE 1 0.0004
91 TEMPERATURE REGULATION DISORDER 1 0.0004
92 FACIAL PAIN 4 0.0004
93 BRAIN FOG 7 0.0004
94 SNEEZING 10 0.0004
95 SUSPECTED OFF LABEL USE 2 0.0004
96 BURNING SENSATION 31 0.0004
97 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
98 RETCHING 9 0.0004
99 EOSINOPHIL COUNT DECREASED 1 0.0004
100 FIBROMYALGIA 10 0.0004
101 INCORRECT DOSAGE ADMINISTERED 2 0.0004
102 CATHETER SITE HAEMORRHAGE 1 0.0004
103 EAR DISCOMFORT 4 0.0004
104 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
105 BLOOD SODIUM INCREASED 1 0.0004
106 EAR CONGESTION 1 0.0004
107 PLEURITIC PAIN 1 0.0004
108 ELECTRIC SHOCK SENSATION 1 0.0004
109 ANGINA PECTORIS 10 0.0003
110 VOMITING PROJECTILE 1 0.0003
111 ESCHERICHIA SEPSIS 1 0.0003
112 HYPOTHYROIDISM 11 0.0003
113 PULMONARY PAIN 1 0.0003
114 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
115 NEGATIVE THOUGHTS 1 0.0003
116 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
117 INFUSION SITE REACTION 1 0.0003
118 LACRIMATION INCREASED 10 0.0003
119 NASAL DRYNESS 2 0.0003
120 SWELLING OF EYELID 2 0.0003
121 BLADDER PAIN 1 0.0003
122 SALIVARY HYPERSECRETION 3 0.0003
123 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
124 SINUS CONGESTION 4 0.0003
125 HYPOPNOEA 1 0.0003
126 LYMPHADENOPATHY 10 0.0003
127 HEAD DISCOMFORT 5 0.0003
128 FIBRIN D DIMER INCREASED 1 0.0003
129 MONOCYTE COUNT INCREASED 1 0.0003
130 PAROSMIA 2 0.0003
131 CATHETER SITE INFECTION 1 0.0003
132 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
133 TRIGEMINAL NEURALGIA 1 0.0002
134 RHINORRHOEA 16 0.0002
135 OSTEOPOROSIS 10 0.0002
136 NASAL CONGESTION 14 0.0002
137 SLEEP TERROR 1 0.0002
138 TONGUE DISCOMFORT 1 0.0002
139 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
140 RECTAL HAEMORRHAGE 10 0.0002
141 TONGUE DISCOLOURATION 1 0.0002
142 DIVERTICULUM INTESTINAL 1 0.0002
143 RHINITIS ALLERGIC 1 0.0002
144 ILEUS PARALYTIC 1 0.0002
145 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
146 HYPOKALAEMIA 10 0.0002
147 OROPHARYNGEAL PAIN 20 0.0002
148 ORAL DISCOMFORT 3 0.0002
149 EPISTAXIS 16 0.0002
150 PHOTOPHOBIA 4 0.0002
151 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
152 HUMERUS FRACTURE 1 0.0002
153 APPLICATION SITE BURN 1 0.0002
154 SINUS DISORDER 4 0.0002
155 PETIT MAL EPILEPSY 1 0.0002
156 EYE IRRITATION 11 0.0002
157 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
158 THROAT TIGHTNESS 5 0.0002
159 NORMAL NEWBORN 1 0.0002
160 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
161 DEVICE DEFECTIVE 3 0.0002
162 HYPERVENTILATION 1 0.0002
163 STRESS CARDIOMYOPATHY 1 0.0002
164 COLD SWEAT 3 0.0002
165 PLEURISY 1 0.0002
166 TOOTHACHE 3 0.0002
167 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
168 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
169 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
170 EYE SWELLING 6 0.0002
171 NECK PAIN 9 0.0002
172 AGEUSIA 4 0.0002
173 PHOTOPSIA 1 0.0002
174 MYDRIASIS 2 0.0002
175 VOMITING 71 0.0002
176 SKIN MASS 1 0.0001
177 WRONG PRODUCT ADMINISTERED 1 0.0001
178 DYSPHAGIA 14 0.0001
179 PERIPHERAL COLDNESS 2 0.0001
180 RESPIRATION ABNORMAL 1 0.0001
181 DROOLING 1 0.0001
182 THERMAL BURN 1 0.0001
183 PARAESTHESIA ORAL 2 0.0001
184 ORAL DISORDER 1 0.0001
185 GENERAL SYMPTOM 1 0.0001
186 HYPOAESTHESIA ORAL 2 0.0001
187 AORTIC ANEURYSM 1 0.0001
188 ATRIOVENTRICULAR BLOCK 1 0.0001
189 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
190 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
191 PRODUCT USE COMPLAINT 2 0.0001
192 SENSORY DISTURBANCE 2 0.0001
193 RHINITIS 1 0.0001
194 MENTAL IMPAIRMENT 3 0.0001
195 FRUSTRATION TOLERANCE DECREASED 1 0.0001
196 SWELLING FACE 8 0.0001
197 PERICARDITIS 2 0.0001
198 VITAMIN D DECREASED 1 0.0001
199 CARDIAC OPERATION 1 0.0001
200 MUSCLE STRAIN 1 0.0001
201 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
202 NAIL DISORDER 1 0.0001
203 BLOOD CALCIUM INCREASED 1 0.0001
204 PRODUCT COMMUNICATION ISSUE 1 0.0001
205 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
206 DRUG INEFFECTIVE 147 0.0001
207 ANAL INCONTINENCE 1 0.0001
208 PANIC ATTACK 4 0.0001
209 RETINAL DETACHMENT 1 0.0001
210 ANAPHYLACTIC REACTION 6 0.0001
211 APPENDICITIS 1 0.0001
212 OCULAR HYPERAEMIA 5 0.0001
213 EYE INFLAMMATION 1 0.0001
214 ATRIAL FIBRILLATION 10 0.0001
215 AUTOIMMUNE DISORDER 1 0.0001
216 NAUSEA 81 0.0001
217 PRODUCT ADMINISTRATION ERROR 2 0.0001
218 DRY THROAT 1 0.0001
219 INJURY ASSOCIATED WITH DEVICE 2 0.0001
220 EUPHORIC MOOD 1 0.0001
221 INITIAL INSOMNIA 1 0.0001
222 SWOLLEN TONGUE 3 0.0001
223 TENDERNESS 1 0.0001
224 BIPOLAR DISORDER 1 0.0001
225 DENTAL CARIES 1 0.0001
226 TOOTH DISORDER 2 0.0001
227 SKIN INFECTION 1 0.0001
228 INTESTINAL PERFORATION 1 0.0001
229 DERMATITIS CONTACT 1 0.0001
230 MYOCARDITIS 1 0.0001
231 ELECTROLYTE IMBALANCE 1 0.0001
232 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
233 SPINAL PAIN 1 0.0001
234 MUSCLE RIGIDITY 1 0.0001
235 WRIST FRACTURE 1 0.0001
236 PHARYNGITIS 1 0.0001
237 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
238 PALLOR 2 0.0001
239 FEELING COLD 2 0.0001
240 WOUND 2 0.0001
241 PAIN IN JAW 2 0.0001
242 SINUS TACHYCARDIA 1 0.0001
243 HYPERSOMNIA 2 0.0001
244 ANOSMIA 1 0.0001
245 HYPERTHYROIDISM 1 0.0001
246 CHEST DISCOMFORT 7 0.0001
247 ILLNESS 7 0.0001
248 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
249 HYPOAESTHESIA 10 0.0001
250 HYPERTENSION 14 0.0001
251 INJECTION SITE RASH 2 0.0001
252 EJECTION FRACTION DECREASED 1 0.0001
253 MENINGIOMA 1 0.0001
254 PNEUMOTHORAX 1 0.0001
255 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
256 MANIA 1 0.0001
257 HEADACHE 38 0.0001
258 EYE PRURITUS 2 0.0001
259 CANDIDA INFECTION 1 0.0001
260 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
261 DEVICE USE ERROR 2 0.0001
262 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
263 SKIN BURNING SENSATION 4 0.0001
264 THINKING ABNORMAL 1 0.0001
265 BLISTER 3 0.0001
266 EYE PAIN 3 0.0001
267 BLOOD URINE PRESENT 1 0.0001
268 MUSCULOSKELETAL DISORDER 1 0.0001
269 FEELING JITTERY 1 0.0001
270 SLEEP APNOEA SYNDROME 1 0.0001
271 POST PROCEDURAL COMPLICATION 1 0.0001
272 GLAUCOMA 1 0.0001
273 PRESCRIBED OVERDOSE 1 0.0001
274 DYSTONIA 1 0.0001
275 EAR PAIN 1 0.0001
276 PALPITATIONS 6 0.0001
277 SURGERY 3 0.0001
278 BLOOD PRESSURE ABNORMAL 1 0.0001
279 COMPLICATION OF DEVICE INSERTION 1 0.0001
280 DYSKINESIA 2 0.0000
281 DISCOMFORT 3 0.0000
282 BODY TEMPERATURE INCREASED 1 0.0000
283 FEELING HOT 3 0.0000
284 PULMONARY HYPERTENSION 1 0.0000
285 DERMATITIS 1 0.0000
286 ABDOMINAL DISCOMFORT 8 0.0000
287 IMPAIRED WORK ABILITY 1 0.0000
288 MENTAL DISORDER 2 0.0000
289 PRODUCT PRESCRIBING ISSUE 1 0.0000
290 INTENTIONAL PRODUCT MISUSE 4 0.0000
291 APPLICATION SITE PAIN 1 0.0000
292 TACHYCARDIA 4 0.0000
293 ORAL PAIN 1 0.0000
294 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
295 THERAPY NON-RESPONDER 2 0.0000
296 PRURITUS 17 0.0000
297 DIZZINESS 22 0.0000
298 VISION BLURRED 6 0.0000
299 NEPHROLITHIASIS 2 0.0000
300 MUSCLE TWITCHING 1 0.0000
301 PERICARDIAL EFFUSION 1 0.0000
302 COGNITIVE DISORDER 2 0.0000
303 TREMOR 7 0.0000
304 PRODUCT PRESCRIBING ERROR 1 0.0000
305 RASH ERYTHEMATOUS 2 0.0000
306 PRESYNCOPE 1 0.0000
307 NEURALGIA 1 0.0000
308 OFF LABEL USE 36 0.0000
309 HEART RATE INCREASED 4 0.0000
310 DRY EYE 2 0.0000
311 PRODUCT COMPLAINT 1 0.0000
312 INJECTION SITE SWELLING 3 0.0000
313 HYPOPHAGIA 1 0.0000
314 ERYTHEMA 8 0.0000
315 ANAPHYLACTIC SHOCK 1 0.0000
316 EXPOSURE VIA SKIN CONTACT 1 0.0000
317 RESPIRATORY TRACT INFECTION 1 0.0000
318 DEAFNESS 1 0.0000
319 SPEECH DISORDER 2 0.0000
320 PARAESTHESIA 6 0.0000
321 JOINT STIFFNESS 1 0.0000
322 GASTRITIS 1 0.0000
323 BLOOD BILIRUBIN INCREASED 1 0.0000
324 CONSTIPATION 8 0.0000
325 MALAISE 16 0.0000
326 PROCEDURAL PAIN 1 0.0000
327 FLATULENCE 2 0.0000
328 LETHARGY 2 0.0000
329 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
330 LIVER FUNCTION TEST ABNORMAL 1 0.0000
331 DYSSTASIA 1 0.0000
332 DYSPHONIA 2 0.0000
333 CHILLS 4 0.0000
334 ACUTE MYOCARDIAL INFARCTION 1 0.0000
335 LABORATORY TEST ABNORMAL 1 0.0000
336 PSYCHOTIC DISORDER 1 0.0000
337 URINARY INCONTINENCE 1 0.0000
338 WHEEZING 2 0.0000
339 ARTHRALGIA 14 0.0000
340 CATARACT 2 0.0000
341 RESPIRATORY DISORDER 1 0.0000
342 BLOOD POTASSIUM DECREASED 1 0.0000
343 APHASIA 1 0.0000
344 VERTIGO 2 0.0000
345 NASOPHARYNGITIS 6 0.0000
346 EMOTIONAL DISORDER 1 0.0000
347 CHEST PAIN 6 0.0000
348 SWELLING 3 0.0000
349 ANXIETY 9 0.0000
350 CYSTITIS 1 0.0000
351 MOOD SWINGS 1 0.0000
352 MOVEMENT DISORDER 1 0.0000
353 NIGHT SWEATS 1 0.0000
354 CHOLELITHIASIS 1 0.0000
355 EYE DISORDER 1 0.0000
356 BLOOD PRESSURE DECREASED 2 0.0000
357 VIRAL INFECTION 1 0.0000
358 GAIT INABILITY 1 0.0000
359 INJECTION SITE PRURITUS 2 0.0000
360 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
361 HAEMORRHAGE 3 0.0000
362 RASH MACULAR 1 0.0000
363 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
364 CEREBRAL HAEMORRHAGE 1 0.0000
365 RASH 12 0.0000
366 HYPERGLYCAEMIA 1 0.0000
367 ACCIDENTAL OVERDOSE 1 0.0000
368 AGITATION 2 0.0000
369 DYSURIA 1 0.0000
370 HYPERSENSITIVITY 5 0.0000
371 DYSARTHRIA 1 0.0000
372 INTESTINAL OBSTRUCTION 1 0.0000
373 UNEVALUABLE EVENT 2 0.0000
374 CONDITION AGGRAVATED 8 0.0000
375 PAIN 16 0.0000
376 ABNORMAL BEHAVIOUR 1 0.0000
377 DRUG INTERACTION 4 0.0000
378 FEELING ABNORMAL 6 0.0000
379 SOMNOLENCE 5 0.0000
380 FATIGUE 19 0.0000
381 LUNG NEOPLASM MALIGNANT 1 0.0000
382 ABDOMINAL PAIN UPPER 5 0.0000
383 POLLAKIURIA 1 0.0000
384 LOSS OF CONSCIOUSNESS 3 0.0000
385 HYPOACUSIS 1 0.0000
386 DYSPNOEA 13 0.0000
387 INSOMNIA 6 0.0000
388 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
389 SKIN IRRITATION 1 0.0000
390 TINNITUS 1 0.0000
391 SKIN DISCOLOURATION 1 0.0000
392 BLOOD CHOLESTEROL INCREASED 1 0.0000
393 ARRHYTHMIA 1 0.0000
394 MULTIPLE SCLEROSIS 1 0.0000
395 FLUSHING 2 0.0000
396 BLOOD PRESSURE INCREASED 3 0.0000
397 INFLAMMATION 1 0.0000
398 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
399 ABDOMINAL DISTENSION 2 0.0000
400 NERVOUSNESS 1 0.0000
401 DISTURBANCE IN ATTENTION 1 0.0000
402 OEDEMA 1 0.0000
403 COUGH 5 0.0000
404 OXYGEN SATURATION DECREASED 1 0.0000
405 ASTHMA 2 0.0000
406 COVID-19 3 0.0000
407 BONE PAIN 1 0.0000
408 PRODUCT DOSE OMISSION ISSUE 5 0.0000
409 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
410 THERAPEUTIC RESPONSE DECREASED 1 0.0000
411 EXPOSURE DURING PREGNANCY 1 0.0000
412 PRODUCT USE ISSUE 3 0.0000
413 INTENTIONAL OVERDOSE 1 0.0000
414 HYPERHIDROSIS 2 0.0000
415 DEVICE DIFFICULT TO USE 1 0.0000
416 INFUSION RELATED REACTION 1 0.0000
417 DRY SKIN 2 0.0000
418 HEPATIC ENZYME INCREASED 1 0.0000
419 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
420 INJECTION SITE REACTION 1 0.0000
421 DEVICE MALFUNCTION 1 0.0000
422 MOBILITY DECREASED 1 0.0000
423 ASTHENIA 5 0.0000
424 HOT FLUSH 1 0.0000
425 DIABETES MELLITUS 1 0.0000
426 INJECTION SITE PAIN 4 0.0000
427 BACK PAIN 3 0.0000
428 ARTHRITIS 1 0.0000
429 INJECTION SITE BRUISING 1 0.0000
430 INJECTION SITE HAEMORRHAGE 1 0.0000
431 THROMBOSIS 1 0.0000
432 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
433 URTICARIA 2 0.0000
434 SKIN EXFOLIATION 1 0.0000
435 CEREBROVASCULAR ACCIDENT 2 0.0000
436 PRODUCT STORAGE ERROR 1 0.0000
437 GASTROINTESTINAL DISORDER 1 0.0000
438 DEVICE ISSUE 1 0.0000
439 ADVERSE DRUG REACTION 1 0.0000
440 SUICIDAL IDEATION 1 0.0000
441 MUSCLE SPASMS 2 0.0000
442 PULMONARY EMBOLISM 1 0.0000
443 GAIT DISTURBANCE 2 0.0000
444 CONTUSION 1 0.0000
445 DRUG INTOLERANCE 1 0.0000
446 DYSPEPSIA 1 0.0000
447 HYPOTENSION 2 0.0000
448 DIARRHOEA 6 0.0000
449 OVERDOSE 2 0.0000
450 JOINT SWELLING 1 0.0000
451 INJECTION SITE ERYTHEMA 1 0.0000
452 DEHYDRATION 1 0.0000
453 MEMORY IMPAIRMENT 1 0.0000
454 INFECTION 1 0.0000
455 HOSPITALISATION 1 0.0000
456 PERIPHERAL SWELLING 1 0.0000
457 FALL 2 0.0000
458 URINARY TRACT INFECTION 1 0.0000
459 BLOOD GLUCOSE INCREASED 1 0.0000
460 ANAEMIA 1 0.0000
461 ALOPECIA 1 0.0000
462 DEPRESSION 1 0.0000
463 INCORRECT DOSE ADMINISTERED 1 0.0000
464 DECREASED APPETITE 1 0.0000
465 ABDOMINAL PAIN 1 0.0000
466 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
467 PAIN IN EXTREMITY 1 0.0000
468 PNEUMONIA 1 0.0000
469 PYREXIA 1 0.0000